Anesiva Inc. recently announced the FDA has approved Zingo (lidocaine hydrochloride monohydrate) powder intradermal injection system, which provides rapid, topical, local analgesia to reduce the pain associated with venous access procedures, such as IV insertions or blood draws, in children ages three to 18.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now